Postmenopausal women taking oestrogen-only hormone replacement therapy or tibolone have a greater risk of endometrial cancer than those taking combination HRT,say researchers.However,they note that since the risk of breast cancer is greater with combination HRT,total cancer incidence remains higher for combined HRT (Lancet 2()()5;365:1543).
展开▼